Published in Hepatitis Weekly, September 25th, 2000
Some previous reports have indicated an increased incidence of autoimmune diseases in HCV patients. The goal of C. Betterle and colleagues was to determine whether HCV patients in Italy would have a higher prevalence of autoimmune diseases or autoantibodies following treatment with IFN-alpha.
Seventy patients with chronic HCV were selected to participate in the research project. Many tests were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.